Navigating Diabetes Treatment: Can You Take Insulin with Ozempic®?

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many people with type 2 diabetes wonder whether they can safely take insulin alongside GLP-1 receptor agonist medications like semaglutide (Ozempic). The short answer is yes—but combining these therapies demands close medical supervision and understanding of how each medication works in your body.

How Insulin and GLP-1 Medications Work Together

Insulin and GLP-1 agonists address blood sugar through different mechanisms. Insulin directly lowers glucose by helping cells absorb sugar from your bloodstream, while GLP-1 medications like semaglutide slow stomach emptying, increase insulin release from your pancreas, and improve how your body uses existing insulin. When used together, they create complementary effects that can achieve stronger glucose control than either medication alone.

The combination is particularly valuable for people whose pancreas struggles to produce enough insulin or whose bodies have become resistant to insulin's effects. Research shows that adding a GLP-1 medication to an existing insulin regimen can improve A1C levels by an additional 1–2 percentage points beyond what insulin alone achieves. This dual approach reduces the workload on your pancreas while enhancing your body's natural insulin sensitivity.

Hypoglycemia Risk: Why Blood Sugar Monitoring Matters

The primary concern when combining insulin with semaglutide or other GLP-1 drugs is low blood sugar (hypoglycemia). Because both medications lower glucose levels, the risk of your blood sugar dropping too far increases—especially during the first weeks of treatment or when insulin doses haven't been adjusted downward. Symptoms like shakiness, sweating, confusion, or rapid heartbeat should never be ignored and require immediate attention.

Your medical provider typically reduces insulin doses by 15–50% when starting a GLP-1 medication, depending on your baseline glucose readings and how well your diabetes has been controlled. Frequent blood sugar monitoring—either through fingerstick tests or continuous glucose monitors—becomes essential to catch dangerous lows and guide further dose adjustments. Many patients find that as their GLP-1 therapy takes effect, insulin requirements drop significantly over weeks or months.

When Doctors Recommend Insulin Plus GLP-1 Combination Therapy

Combination therapy is most often recommended for people with type 2 diabetes who have failed to reach target A1C levels on insulin alone, or who require very high insulin doses that increase injection burden and risk of weight gain. Patients with long-standing diabetes, those with declining pancreatic function, or individuals with significant insulin resistance frequently benefit from this two-drug approach. Adding a GLP-1 medication often allows your provider to reduce overall insulin doses while improving glucose control—a win-win outcome.

People taking multiple daily insulin injections or pump therapy are excellent candidates because GLP-1 medications can sometimes reduce the total daily insulin requirement by 20–40%. This means fewer injections, lower costs, and improved quality of life. Your endocrinologist or diabetes care team will assess your individual situation, including your A1C, kidney function, and cardiovascular health, to determine whether this combination makes sense for you.

PlexusDx Semaglutide and Personalized Diabetes Management

PlexusDx provides compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan from licensed 503A compounding pharmacies, offering an affordable option for those exploring GLP-1 therapy—whether as monotherapy or in combination with existing insulin regimens. PlexusDx serves all 50 states without requiring insurance, making consistent, personalized GLP-1 access available to more people managing type 2 diabetes. Each patient receives guidance on how their specific medication works with their current treatment plan.

For those interested in understanding their genetic predisposition to respond well to GLP-1 or insulin therapies, PlexusDx offers the Precision Peptide Genetic Test ($298). This peptide-pathway genetic test examines key variants in GLP-1 and insulin signaling genes—including GIPR rs1800437, and others—mapping 14 pathways across 49 peptides to reveal 150+ genetic insights. These results help your care team tailor your insulin-GLP-1 combination for maximum effectiveness based on your unique biology.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Is it safe to take insulin and Ozempic at the same time?

Yes, combining insulin with semaglutide (Ozempic) is safe when managed by a healthcare provider. Your doctor will lower your insulin dose to prevent low blood sugar and monitor your glucose levels closely during the transition. This combination often achieves better blood sugar control than either medication alone.

How much will my insulin dose need to decrease when starting a GLP-1 medication?

Insulin reductions typically range from 15–50% depending on your current glucose control and baseline insulin requirement. Your provider will adjust your doses gradually based on blood sugar readings and A1C trends. Some patients experience continued dose reductions over several months as their GLP-1 therapy becomes fully effective.

What is the cost of PlexusDx semaglutide, and does it work with insulin?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and are available nationwide without insurance requirements. Your dose may need to go up—your price won't. PlexusDx semaglutide integrates seamlessly with existing insulin therapy when prescribed and monitored by your healthcare team.

What are the signs of low blood sugar when taking insulin plus GLP-1 medication together?

Watch for shakiness, sweating, dizziness, confusion, rapid heartbeat, or intense hunger. These symptoms require immediate action—consume fast-acting carbohydrates (glucose tablets, juice, or candy) and contact your doctor. Continuous glucose monitoring can alert you to drops before dangerous symptoms develop.

How can the Precision Peptide Genetic Test help me with insulin and GLP-1 therapy?

The Precision Peptide Genetic Test examines variants in GIPR, and other peptide-pathway genes to reveal how your body may respond to GLP-1 medications and insulin. PlexusDx maps 14 pathways and 150+ genetic insights, helping your doctor personalize your combination therapy for better outcomes. The test is available at $298.

Related Reading

• Ozempic For Type 2 Diabetes 2
• Ozempic For Diabetes 2
• Ozempic Diabetes
• Ozempic For Diabetes

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.